Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

Kiuchi T, Ortiz-Zapater E, Monypenny J, Matthews DR, Nguyen LK, Barbeau J, Coban O, Lawler K, Burford B, Rolfe DJ, de Rinaldis E, Dafou D, Simpson MA, Woodman N, Pinder S, Gillett CE, Devauges V, Poland SP, Fruhwirth G, Marra P, Boersma YL, Plückthun A, Gullick WJ, Yarden Y, Santis G, Winn M, Kholodenko BN, Martin-Fernandez ML, Parker P, Tutt A, Ameer-Beg SM, Ng T.

Sci Signal. 2014 Aug 19;7(339):ra78. doi: 10.1126/scisignal.2005157.

PMID:
25140053
[PubMed - in process]
2.

Therapeutic targeting of integrin αvβ6 in breast cancer.

Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR, Haider S, Brouilette K, Saha A, Vallath S, Bowen R, Chelala C, Eccles D, Tapper WJ, Thompson AM, Quinlan P, Jordan L, Gillett C, Brentnall A, Violette S, Weinreb PH, Kendrew J, Barry ST, Hart IR, Jones JL, Marshall JF.

J Natl Cancer Inst. 2014 Jun 28;106(8). pii: dju169. doi: 10.1093/jnci/dju169. Print 2014 Aug.

PMID:
24974129
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Bulk de novo mitogenome assembly from pooled total DNA elucidates the phylogeny of weevils (Coleoptera: Curculionoidea).

Gillett CP, Crampton-Platt A, Timmermans MJ, Jordal BH, Emerson BC, Vogler AP.

Mol Biol Evol. 2014 Aug;31(8):2223-37. doi: 10.1093/molbev/msu154. Epub 2014 May 6.

PMID:
24803639
[PubMed - in process]
Free PMC Article
4.

Prophylactic antibiotics in interventional paediatric cardiac catheterisation: old habits die hard?

Gillett CD, Morgan GJ.

Cardiol Young. 2014 Apr 28:1-5. [Epub ahead of print]

PMID:
24776072
[PubMed - as supplied by publisher]
5.

Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship.

Purushotham A, Shamil E, Cariati M, Agbaje O, Muhidin A, Gillett C, Mera A, Sivanadiyan K, Harries M, Sullivan R, Pinder SE, Garmo H, Holmberg L.

Eur J Cancer. 2014 Jul;50(10):1697-705. doi: 10.1016/j.ejca.2014.04.002. Epub 2014 Apr 23.

PMID:
24768572
[PubMed - indexed for MEDLINE]
6.

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, Fletcher O, Pinder S, Hanby A, Kohut K, Gorman P, Caneppele M, Peto J, Dos Santos Silva I, Johnson N, Swann R, Dwek M, Perkins KA, Gillett C, Houlston R, Ross G, De Ieso P, Southey MC, Hopper JL, Provenzano E, Apicella C, Wesseling J, Cornelissen S, Keeman R, Fasching PA, Jud SM, Ekici AB, Beckmann MW, Kerin MJ, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Laurent-Puig P, Kerbrat P, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Perez JI, Menéndez P, Benitez J, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Lochmann M, Brauch H, Fischer HP, Ko YD; GENICA Network, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Dörk T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Chenevix-Trench G, Investigators K, Lambrechts D, Weltens C, Van Limbergen E, Hatse S, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Volorio S, Giles GG, Severi G, Baglietto L, McLean CA, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Kristensen V, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devillee P, Tollenaar RA, Seynaeve CM, Kriege M, Figueroa J, Chanock SJ, Sherman ME, Hooning MJ, Hollestelle A, van den Ouweland AM, van Deurzen CH, Li J, Czene K, Humphreys K, Cox A, Cross SS, Reed MW, Shah M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Couch FJ, Hallberg E, González-Neira A, Pita G, Alonso MR, Tessier DC, Vincent D, Bacot F, Bolla MK, Wang Q, Dennis J, Michailidou K, Dunning AM, Hall P, Easton D, Pharoah P, Schmidt MK, Tomlinson I, Garcia-Closas M.

PLoS Genet. 2014 Apr 17;10(4):e1004285. doi: 10.1371/journal.pgen.1004285. eCollection 2014 Apr.

PMID:
24743323
[PubMed - in process]
Free PMC Article
7.

Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.

Wong PP, Yeoh CC, Ahmad AS, Chelala C, Gillett C, Speirs V, Jones JL, Hurst HC.

Oncogene. 2014 Sep 11;33(37):4579-88. doi: 10.1038/onc.2014.45. Epub 2014 Mar 24.

PMID:
24662835
[PubMed - in process]
8.

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.

Irshad S, Gillett C, Pinder SE, A'hern RP, Dowsett M, Ellis IO, Bartlett JM, Bliss JM, Hanby A, Johnston S, Barrett-Lee P, Ellis P, Tutt A.

Breast Cancer Res Treat. 2014 Apr;144(2):331-41. doi: 10.1007/s10549-014-2855-4. Epub 2014 Feb 12.

PMID:
24519386
[PubMed - in process]
9.

An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk.

Yau C, Sninsky J, Kwok S, Wang A, Degnim A, Ingle JN, Gillett C, Tutt A, Waldman F, Moore D, Esserman L, Benz CC.

Breast Cancer Res. 2013;15(5):R103.

PMID:
24172169
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control.

de Rinaldis E, Gazinska P, Mera A, Modrusan Z, Fedorowicz GM, Burford B, Gillett C, Marra P, Grigoriadis A, Dornan D, Holmberg L, Pinder S, Tutt A.

BMC Genomics. 2013 Sep 23;14:643. doi: 10.1186/1471-2164-14-643.

PMID:
24059244
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer.

Youssef G, Gillett C, Agbaje O, Crompton T, Montano X.

Mod Pathol. 2014 Mar;27(3):361-74. doi: 10.1038/modpathol.2013.129. Epub 2013 Aug 16.

PMID:
23948750
[PubMed - in process]
12.

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.

Gazinska P, Grigoriadis A, Brown JP, Millis RR, Mera A, Gillett CE, Holmberg LH, Tutt AN, Pinder SE.

Mod Pathol. 2013 Jul;26(7):955-66. doi: 10.1038/modpathol.2012.244. Epub 2013 Feb 8.

PMID:
23392436
[PubMed - indexed for MEDLINE]
Free Article
13.

Cultural competence training for clinical staff: measuring the effect of a one-hour class on cultural competence.

Delgado DA, Ness S, Ferguson K, Engstrom PL, Gannon TM, Gillett C.

J Transcult Nurs. 2013 Apr;24(2):204-13. doi: 10.1177/1043659612472059. Epub 2013 Feb 6.

PMID:
23389745
[PubMed - indexed for MEDLINE]
14.

Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Gazinska P, Herman D, Gillett C, Pinder S, Mantle P.

Toxins (Basel). 2012 Sep;4(9):643-62. doi: 10.3390/toxins4090643. Epub 2012 Sep 11.

PMID:
23105973
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.

Pinder SE, Brown JP, Gillett C, Purdie CA, Speirs V, Thompson AM, Shaaban AM; Translational Subgroup of the NCRI Breast Clinical Studies Group.

J Clin Pathol. 2013 Mar;66(3):169-77. doi: 10.1136/jclinpath-2012-201091. Epub 2012 Oct 19. Review.

PMID:
23087330
[PubMed - indexed for MEDLINE]
16.

Targeting the HOX/PBX dimer in breast cancer.

Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael A, Pandha HS.

Breast Cancer Res Treat. 2012 Nov;136(2):389-98. doi: 10.1007/s10549-012-2259-2. Epub 2012 Sep 30.

PMID:
23053648
[PubMed - indexed for MEDLINE]
17.

Patterns of metastasis in women with metachronous contralateral breast cancer.

Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M.

Br J Cancer. 2012 Jul 10;107(2):221-3. doi: 10.1038/bjc.2012.273. Epub 2012 Jun 26.

PMID:
22735901
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.

Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM.

Cancer Res. 2011 Dec 15;71(24):7683-93. doi: 10.1158/0008-5472.CAN-11-1139. Epub 2011 Oct 24.

PMID:
22025563
[PubMed - indexed for MEDLINE]
Free Article
19.

Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.

Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M.

Breast Cancer Res Treat. 2011 Nov;130(2):609-18. doi: 10.1007/s10549-011-1618-8. Epub 2011 Jun 14.

PMID:
21671018
[PubMed - indexed for MEDLINE]
20.

Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways.

Vichapat V, Gillett C, Fentiman IS, Tutt A, Holmberg L, Lüchtenborg M.

Eur J Cancer. 2011 Sep;47(13):1919-27. doi: 10.1016/j.ejca.2011.05.004. Epub 2011 Jun 12.

PMID:
21658939
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk